Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mizuho

6.43
+0.19003.04%
Post-market: 6.540.1100+1.71%17:20 EDT
Volume:1.72M
Turnover:11.06M
Market Cap:80.11B
PE:13.19
High:6.44
Open:6.37
Low:6.35
Close:6.24
52wk High:6.44
52wk Low:3.83
Shares:12.46B
Float Shares:11.34B
Volume Ratio:1.10
T/O Rate:0.02%
Dividend:0.19
Dividend Rate:2.95%
EPS(TTM):0.4875
EPS(LYR):0.4677
ROE:8.47%
ROA:0.31%
PB:1.12
PE(LYR):13.75

Loading ...

Mizuho Securities Keeps Their Hold Rating on Intel (INTC)

TIPRANKS
·
Jul 25

Atlas Engineered Products Expands with Acquisition of Penn-Truss MFG Inc.

TIPRANKS
·
Jul 25

Las Vegas Sands Is Maintained at Outperform by Mizuho

Dow Jones
·
Jul 25

Mizuho Securities Sticks to Their Hold Rating for Mobileye Global, Inc. Class A (MBLY)

TIPRANKS
·
Jul 25

Mizuho Securities Remains a Buy on JD (JD)

TIPRANKS
·
Jul 24

Boston Scientific (BSX) Gets a Buy from Mizuho Securities

TIPRANKS
·
Jul 24

Mizuho Securities Sticks to Its Buy Rating for RPM International (RPM)

TIPRANKS
·
Jul 24

Mizuho Securities Initiates Coverage on Braze With Outperform Rating, $40 Price Target

MT Newswires Live
·
Jul 24

Travel + Leisure upgraded to Outperform from Neutral at Mizuho

TIPRANKS
·
Jul 24

Braze initiated with an Outperform at Mizuho

TIPRANKS
·
Jul 24

One REIT Signs 5 Billion Yen Credit Line Agreement With Mizuho Bank

MT Newswires Live
·
Jul 24

Range Resources Is Maintained at Outperform by Mizuho

Dow Jones
·
Jul 24

Mizuho Securities Keeps Their Hold Rating on Athira Pharma (ATHA)

TIPRANKS
·
Jul 23

Constellation Energy Corporation (CEG) Receives a Hold from Mizuho Securities

TIPRANKS
·
Jul 23

Texas Instruments (TXN) Receives a Hold from Mizuho Securities

TIPRANKS
·
Jul 23

General Motors (GM) Receives a Buy from Mizuho Securities

TIPRANKS
·
Jul 23

Cadence Design Systems Is Maintained at Outperform by Mizuho

Dow Jones
·
Jul 23

Churchill Downs Is Maintained at Outperform by Mizuho

Dow Jones
·
Jul 23

Mizuho Securities Adjusts Cadence Design Systems Price Target to $360 From $325, Maintains Outperform Rating

MT Newswires Live
·
Jul 22

Mizuho Securities Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)

TIPRANKS
·
Jul 22